Innospec Past Earnings Performance
Past criteria checks 4/6
Innospec has been growing earnings at an average annual rate of 16.6%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 9.3% per year. Innospec's return on equity is 11.5%, and it has net margins of 7.7%.
Key information
16.6%
Earnings growth rate
16.2%
EPS growth rate
Chemicals Industry Growth | 12.9% |
Revenue growth rate | 9.3% |
Return on equity | 11.5% |
Net Margin | 7.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Do Innospec's (NASDAQ:IOSP) Earnings Warrant Your Attention?
Nov 25Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At $0.79
Nov 09Innospec Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 08Pinning Down Innospec Inc.'s (NASDAQ:IOSP) P/E Is Difficult Right Now
Nov 07Returns On Capital At Innospec (NASDAQ:IOSP) Have Stalled
Oct 22At US$110, Is Innospec Inc. (NASDAQ:IOSP) Worth Looking At Closely?
Sep 17Innospec Navigating Turbulent End-Markets And Specialty Chemical De-Rating Relatively Well
Aug 19Estimating The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)
Aug 01Returns On Capital At Innospec (NASDAQ:IOSP) Have Hit The Brakes
Jul 15With EPS Growth And More, Innospec (NASDAQ:IOSP) Makes An Interesting Case
Jun 12Innospec (NASDAQ:IOSP) Is Increasing Its Dividend To $0.76
May 14Innospec Inc.'s (NASDAQ:IOSP) Share Price Could Signal Some Risk
May 08Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward
Apr 11Is Innospec Inc. (NASDAQ:IOSP) Potentially Undervalued?
Mar 28Estimating The Fair Value Of Innospec Inc. (NASDAQ:IOSP)
Mar 15Here's Why We Think Innospec (NASDAQ:IOSP) Might Deserve Your Attention Today
Feb 16Innospec (NASDAQ:IOSP) Hasn't Managed To Accelerate Its Returns
Dec 05What Does Innospec Inc.'s (NASDAQ:IOSP) Share Price Indicate?
Oct 14Here's Why We Think Innospec (NASDAQ:IOSP) Is Well Worth Watching
Sep 11Innospec Inc. (NASDAQ:IOSP) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 26Should You Investigate Innospec Inc. (NASDAQ:IOSP) At US$98.35?
Jul 07Innospec (NASDAQ:IOSP) Is Looking To Continue Growing Its Returns On Capital
Jun 07Is Innospec Inc. (NASDAQ:IOSP) Trading At A 33% Discount?
May 24Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?
May 09Is It Time To Consider Buying Innospec Inc. (NASDAQ:IOSP)?
Apr 04Investors Will Want Innospec's (NASDAQ:IOSP) Growth In ROCE To Persist
Mar 08Does Innospec (NASDAQ:IOSP) Deserve A Spot On Your Watchlist?
Feb 01A Look At The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)
Dec 22Innospec (NASDAQ:IOSP) Is Paying Out A Larger Dividend Than Last Year
Nov 12Return Trends At Innospec (NASDAQ:IOSP) Aren't Appealing
Oct 20Innospec Inc. (NASDAQ:IOSP) Shares Could Be 35% Above Their Intrinsic Value Estimate
Sep 02Here's Why We Think Innospec (NASDAQ:IOSP) Is Well Worth Watching
Aug 19Innospec: A Buy Before The Upcoming Earnings Release
Jul 21Should You Think About Buying Innospec Inc. (NASDAQ:IOSP) Now?
Jul 20Innospec (NASDAQ:IOSP) Has Some Way To Go To Become A Multi-Bagger
Jul 02Innospec (NASDAQ:IOSP) Is Paying Out A Larger Dividend Than Last Year
May 07What Is Innospec Inc.'s (NASDAQ:IOSP) Share Price Doing?
Apr 16Returns At Innospec (NASDAQ:IOSP) Appear To Be Weighed Down
Mar 27Revenue & Expenses Breakdown
How Innospec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,873 | 144 | 326 | 44 |
30 Jun 24 | 1,894 | 150 | 342 | 45 |
31 Mar 24 | 1,939 | 147 | 374 | 43 |
31 Dec 23 | 1,949 | 139 | 378 | 42 |
30 Sep 23 | 1,965 | 127 | 376 | 41 |
30 Jun 23 | 2,014 | 126 | 389 | 40 |
31 Mar 23 | 2,001 | 130 | 367 | 39 |
31 Dec 22 | 1,964 | 133 | 356 | 39 |
30 Sep 22 | 1,866 | 131 | 329 | 40 |
30 Jun 22 | 1,729 | 116 | 304 | 40 |
31 Mar 22 | 1,616 | 106 | 283 | 39 |
31 Dec 21 | 1,483 | 93 | 262 | 37 |
30 Sep 21 | 1,381 | 92 | 247 | 34 |
30 Jun 21 | 1,270 | 81 | 230 | 32 |
31 Mar 21 | 1,160 | 19 | 231 | 31 |
31 Dec 20 | 1,193 | 29 | 237 | 31 |
30 Sep 20 | 1,273 | 37 | 242 | 33 |
30 Jun 20 | 1,380 | 55 | 259 | 35 |
31 Mar 20 | 1,497 | 117 | 266 | 35 |
31 Dec 19 | 1,513 | 112 | 274 | 35 |
30 Sep 19 | 1,518 | 102 | 271 | 35 |
30 Jun 19 | 1,509 | 92 | 265 | 34 |
31 Mar 19 | 1,505 | 92 | 260 | 34 |
31 Dec 18 | 1,477 | 85 | 255 | 33 |
30 Sep 18 | 1,436 | 60 | 256 | 33 |
30 Jun 18 | 1,405 | 63 | 254 | 33 |
31 Mar 18 | 1,373 | 67 | 250 | 32 |
31 Dec 17 | 1,307 | 62 | 240 | 31 |
30 Sep 17 | 1,191 | 89 | 233 | 30 |
30 Jun 17 | 1,064 | 77 | 229 | 28 |
31 Mar 17 | 966 | 80 | 221 | 26 |
31 Dec 16 | 883 | 81 | 210 | 25 |
30 Sep 16 | 892 | 91 | 208 | 26 |
30 Jun 16 | 940 | 115 | 205 | 26 |
31 Mar 16 | 955 | 121 | 202 | 26 |
31 Dec 15 | 1,012 | 120 | 207 | 25 |
30 Sep 15 | 1,057 | 116 | 199 | 24 |
30 Jun 15 | 1,031 | 101 | 188 | 24 |
31 Mar 15 | 1,009 | 85 | 176 | 23 |
31 Dec 14 | 961 | 84 | 169 | 22 |
30 Sep 14 | 912 | 85 | 165 | 22 |
30 Jun 14 | 876 | 78 | 155 | 22 |
31 Mar 14 | 840 | 77 | 148 | 21 |
31 Dec 13 | 819 | 78 | 142 | 21 |
Quality Earnings: IOSP has high quality earnings.
Growing Profit Margin: IOSP's current net profit margins (7.7%) are higher than last year (6.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IOSP's earnings have grown by 16.6% per year over the past 5 years.
Accelerating Growth: IOSP's earnings growth over the past year (13.4%) is below its 5-year average (16.6% per year).
Earnings vs Industry: IOSP earnings growth over the past year (13.4%) exceeded the Chemicals industry 4.8%.
Return on Equity
High ROE: IOSP's Return on Equity (11.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 02:34 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Innospec Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jonathan Tanwanteng | CJS Securities, Inc. |
David Silver | CL King & Associates, Inc. |
Sean Milligan | Johnson Rice & Company, L.L.C. |